Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 2.94% is 66% below its 4-year average of 8.61%, around the middle of its 4-year range (-7.23%–18.61%).
125.60% above its 12-month average of 1.30%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-03-31): -7.23%.
OPERATING MARGIN
2.94%
OPERATING MARGIN AVG TTM
1.30%
OPERATING MARGIN AVG 3Y
6.62%
OPERATING MARGIN AVG 5Y
8.61%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+125.60%
CURRENT VS 3Y AVG
-55.59%
CURRENT VS 5Y AVG
-65.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Jin Medical International Ltd.
Market Cap
$15.58M
Operating Margin
2.94%
TTM Avg
1.30%
3Y Avg
6.62%
5Y Avg
8.61%
Market Cap
$15.68M
Operating Margin
-3939.06%
TTM Avg
-1969.53%
3Y Avg
-984.76%
5Y Avg
-656.51%
Market Cap
$15.78M
Operating Margin
0.00%
TTM Avg
-6897.41%
3Y Avg
-4279.04%
5Y Avg
-4845.03%
Market Cap
$15.30M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-79.33%
Market Cap
$14.94M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-4987.62%
Market Cap
$14.73M
Operating Margin
-56.17%
TTM Avg
-72.17%
3Y Avg
-80.90%
5Y Avg
-88.24%
Market Cap
$16.52M
Operating Margin
-579.88%
TTM Avg
-374.35%
3Y Avg
-344.88%
5Y Avg
-436.34%
Market Cap
$16.64M
Operating Margin
-116.95%
TTM Avg
-227.41%
3Y Avg
-381.13%
5Y Avg
-401.11%
Market Cap
$14.46M
Operating Margin
-859.22%
TTM Avg
-477.88%
3Y Avg
-341.34%
5Y Avg
-316.87%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jin Medical International Ltd. (ZJYL) | $15.58M | 2.94% | 1.30% | 6.62% | 8.61% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | -3939.06% | -1969.53% | -984.76% | -656.51% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | 0.00% | -6897.41% | -4279.04% | -4845.03% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | 0.00% | 0.00% | 0.00% | -79.33% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.94M | 0.00% | 0.00% | 0.00% | -4987.62% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | -56.17% | -72.17% | -80.90% | -88.24% |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | -579.88% | -374.35% | -344.88% | -436.34% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -116.95% | -227.41% | -381.13% | -401.11% |
| Vyome Holdings, Inc. (HIND)vs › | $14.46M | -859.22% | -477.88% | -341.34% | -316.87% |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | -65.74% | -32.87% | -308.88% | 2329.03% |
Gross Margin
29.2%
Operating Margin
2.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | -7.23% |
| 2025-09-30 | 9.83% |
| 2025-03-30 | -4.60% |
| 2024-09-30 | 18.61% |
| 2024-03-30 | 11.64% |
| 2023-09-30 | 11.45% |
| 2023-03-30 | 17.28% |
| 2022-09-30 | 11.46% |
| 2022-03-30 | 10.74% |
| 2021-09-30 | 6.95% |
| 2021-03-30 | 19.57% |
| 2020-09-30 | 13.09% |
| 2020-03-30 | 16.37% |
| 2019-09-30 | 20.93% |
| 2019-03-30 | 22.31% |
